Ready-to-load MHC-I Nanoparticles for High-throughput T cell Screening Studies.

Area of Science:

• Immunology
• Molecular Biology
• Nanotechnology

Background:

• Major histocompatibility complex (MHC) class I proteins present peptides to CD8+ T cells, crucial for adaptive immunity.
• T-cell receptor (TCR) interactions with peptide-MHC complexes determine T cell activation or anergy.
• Understanding these interactions is vital for developing immunotherapies and vaccines.

Purpose of the Study:

• To present a novel, loadable nanoparticle system, VLP-Open HLA, for presenting peptides.
• To demonstrate its utility in screening for novel T-cell receptors (TCRs).
• To show its capability in inducing antigen-specific T cell activation.

Main Methods:

• Development of a virus-like particle (VLP) system, VLP-Open HLA, capable of displaying up to 60 human leukocyte antigen (HLA) molecules.
• Utilizing pre-loaded HLA nanoparticles for efficient peptide exchange with target peptides.
• Employing fluorescently tagged VLP-Open HLA particles for staining antigen-specific CD8+ T cells.
• Demonstrating T cell activation induced by the VLP-Open HLA system.

Main Results:

• VLP-Open HLA particles efficiently present peptides via HLA molecules.
• Fluorescently tagged particles successfully stained antigen-specific CD8+ T cells, validating their use as a screening tool for TCRs.
• The system demonstrated the ability to induce antigen-specific T cell activation.

Conclusions:

• VLP-Open HLA provides a versatile platform for presenting peptides and studying T cell interactions.
• This system facilitates the screening of novel TCRs and the induction of antigen-specific T cell responses.
• The platform's adaptability for various HLA allotypes and co-stimulatory molecules opens broad applications in experimental immunology.